Tvardi Therapeutics, Inc.
TVRD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001346830
No open-market purchases or sales by Tvardi Therapeutics, Inc. insiders were filed in the last 90 days; 57 institutions reported holding it in 13F filings for Q2 2026, worth $4.24M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Tvardi Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 186
- +14 vs. Q3 2021
- Shares held
- 30.3M
- +697.2K (+2.4%) vs. Q3 2021
- Total value
- $368.9M
- −$88.3M (−19.3%) vs. Q3 2021
- New holders
- 38
- 49 more added
- Sold out
- 24
- 59 more reduced
1 institution that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TVRD on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 57 | $4.24M |
| Q1 2026 | 67 | $8.60M |
| Q4 2025 | 67 | $12.1M |
| Q3 2025 | 73 | $102.2M |
| Q2 2025 | 56 | $44.9M |
| Q1 2025 | 35 | $3.21M |
| Q4 2024 | 45 | $6.59M |
| Q3 2024 | 71 | $4.17M |
| Q2 2024 | 81 | $4.56M |
| Q1 2024 | 101 | $21.5M |
| Q4 2023 | 112 | $18.1M |
| Q3 2023 | 124 | $45.6M |
| Q2 2023 | 138 | $83.3M |
| Q1 2023 | 164 | $166.4M |
| Q4 2022 | 163 | $364.7M |
| Q3 2022 | 167 | $323.6M |
| Q2 2022 | 183 | $317.9M |
| Q1 2022 | 186 | $385.5M |
| Q4 2021 | 186 | $368.9M |
| Q3 2021 | 173 | $457.1M |
| Q2 2021 | 175 | $444.0M |
| Q1 2021 | 172 | $703.5M |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Tvardi Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Parkside Financial Bank & Trust | 0 | $0 | 0.00% | −275−100.0% | Sold out |
| FourThought Financial, LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −207−100.0% | Sold out |
| NEXT Financial Group, Inc | 0 | $0 | 0.00% | −149−100.0% | Sold out |
| Gables Capital Management Inc. | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| Lindbrook Capital, LLC | 0 | $0 | 0.00% | −70−100.0% | Sold out |
| Fifth Third Bancorp | 0 | $0 | 0.00% | −30−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Trustcore Financial Services, LLC | 0 | $0 | 0.00% | −27−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −8−100.0% | Sold out |
| Wealth Quarterback LLC | – | – | – | – | Not filed |